How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

7,322 results for

Diarrhea Secondary to Medications

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Medical Treatment of Stroke (Overview)

stroke prevention may include the use of antihypertensive medications, anticoagulants, platelet antiaggregants, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins), smoking cessation, dietary intervention, weight loss, and exercise. Modifiable risk factors include the following: Hypertension Air pollution Cigarette smoking Diabetes Dyslipidemia Atrial fibrillation Sickle cell disease Postmenopausal HRT Depression Diet and activity Weight and body fat Secondary Prevention (...) of Stroke Secondary prevention can be summarized by the mnemonic A, B, C, D, E, as follows: A - Antiaggregants (aspirin, clopidogrel, extended-release dipyridamole, ticlopidine) and anticoagulants (apixaban, dabigatran, edoxaban, rivaroxaban, warfarin) B - Blood pressure–lowering medications C - Cessation of cigarette smoking, cholesterol-lowering medications, carotid revascularization D - Diet E – Exercise Smoking cessation, blood pressure control, diabetes control, a low-fat diet (eg, Dietary

2014 eMedicine.com

162. Medical Treatment of Stroke (Diagnosis)

stroke prevention may include the use of antihypertensive medications, anticoagulants, platelet antiaggregants, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins), smoking cessation, dietary intervention, weight loss, and exercise. Modifiable risk factors include the following: Hypertension Air pollution Cigarette smoking Diabetes Dyslipidemia Atrial fibrillation Sickle cell disease Postmenopausal HRT Depression Diet and activity Weight and body fat Secondary Prevention (...) of Stroke Secondary prevention can be summarized by the mnemonic A, B, C, D, E, as follows: A - Antiaggregants (aspirin, clopidogrel, extended-release dipyridamole, ticlopidine) and anticoagulants (apixaban, dabigatran, edoxaban, rivaroxaban, warfarin) B - Blood pressure–lowering medications C - Cessation of cigarette smoking, cholesterol-lowering medications, carotid revascularization D - Diet E – Exercise Smoking cessation, blood pressure control, diabetes control, a low-fat diet (eg, Dietary

2014 eMedicine.com

163. Medical Treatment of Stroke (Follow-up)

stroke prevention may include the use of antihypertensive medications, anticoagulants, platelet antiaggregants, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins), smoking cessation, dietary intervention, weight loss, and exercise. Modifiable risk factors include the following: Hypertension Air pollution Cigarette smoking Diabetes Dyslipidemia Atrial fibrillation Sickle cell disease Postmenopausal HRT Depression Diet and activity Weight and body fat Secondary Prevention (...) of Stroke Secondary prevention can be summarized by the mnemonic A, B, C, D, E, as follows: A - Antiaggregants (aspirin, clopidogrel, extended-release dipyridamole, ticlopidine) and anticoagulants (apixaban, dabigatran, edoxaban, rivaroxaban, warfarin) B - Blood pressure–lowering medications C - Cessation of cigarette smoking, cholesterol-lowering medications, carotid revascularization D - Diet E – Exercise Smoking cessation, blood pressure control, diabetes control, a low-fat diet (eg, Dietary

2014 eMedicine.com

164. Medical Treatment of Stroke (Treatment)

stroke prevention may include the use of antihypertensive medications, anticoagulants, platelet antiaggregants, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins), smoking cessation, dietary intervention, weight loss, and exercise. Modifiable risk factors include the following: Hypertension Air pollution Cigarette smoking Diabetes Dyslipidemia Atrial fibrillation Sickle cell disease Postmenopausal HRT Depression Diet and activity Weight and body fat Secondary Prevention (...) of Stroke Secondary prevention can be summarized by the mnemonic A, B, C, D, E, as follows: A - Antiaggregants (aspirin, clopidogrel, extended-release dipyridamole, ticlopidine) and anticoagulants (apixaban, dabigatran, edoxaban, rivaroxaban, warfarin) B - Blood pressure–lowering medications C - Cessation of cigarette smoking, cholesterol-lowering medications, carotid revascularization D - Diet E – Exercise Smoking cessation, blood pressure control, diabetes control, a low-fat diet (eg, Dietary

2014 eMedicine.com

165. Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial

Posted : April 10, 2015 Sponsor: Chengdu University of Traditional Chinese Medicine Collaborator: Guang'anmen Hospital of China Academy of Chinese Medical Sciences Information provided by (Responsible Party): Chengdu University of Traditional Chinese Medicine Study Details Study Description Go to Brief Summary: This trial is to assess the effectiveness of three types of acupuncture for patients with functional diarrhea comparing to a positive drug control. Condition or disease Intervention/treatment (...) Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2011 Clinical Trials

166. Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit

Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02025855 Recruitment Status : Unknown Verified January 2014 by Thomas Smoot, PharmD, BCPS, Henry

2013 Clinical Trials

167. MEdical Versus SUrgical Treatments of Rectal Endometriosis

MEdical Versus SUrgical Treatments of Rectal Endometriosis MEdical Versus SUrgical Treatments of Rectal Endometriosis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. MEdical Versus SUrgical Treatments (...) of the rectum and not having pregnancy intention. The main outcome concerns the quality of digestive function 24 after the onset of the treatment, assessed using a composite variable: patient considering that digestive function is normal AND the Knowles-Eccersley-Scott-Symptom Questionnaire (KESS score) <7 AND the Gastrointestinal Quality of Life Index (GIQLI) score >100. Secondary outcomes are: presence of severe constipation, increased frequency of daily bowel movements, anal incontinence, postoperative

2013 Clinical Trials

168. Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation

Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study (...) Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov

2013 Clinical Trials

169. Educational-Medical-Behavioral Treatment of Fecal Incontinence

to be effective in single-site studies will sustain its efficacy when disseminated to a home bound population by home health care nurses. The treatment includes patient education about the physiology of how continence is maintained, pelvic floor exercises, behavioral strategies for preventing FI, and use of fiber or nonprescription medication to treat diarrhea or constipation. To minimize drift when the treatment is disseminated to a large group of providers, patient education and other basic components (...) Educational-Medical-Behavioral Treatment of Fecal Incontinence Educational-Medical-Behavioral Treatment of Fecal Incontinence - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Educational-Medical-Behavioral

2012 Clinical Trials

170. A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management. (Full text)

these parameters for a nonhuman primate exposed to total body radiation and administered medical management. A blinded, randomized study (n = 48 rhesus macaques) determined the lethal dose-response relationship using bilateral 6 MV linear accelerator photon radiation to doses in the range of 7.20 to 8.90 Gy at 0.80 Gy min(-1). Following irradiation, animals were monitored for complete bloodcounts, body weight, temperature, diarrhea, and hydration status for 60 d. Animals were administered medical management (...) consisting of intravenous fluids, prophylactic antibiotics, blood transfusions, anti-diarrheals, analgesics, and nutrition. The primary endpoint was survival at 60 d post-irradiation; secondary endpoints included hematopoietic-related parameters, number of transfusions, incidence of documented infection, febrile neutropenia, severity of diarrhea, mean survival time of decedents, and tissue histology. The study defined an LD30/60 of 7.06 Gy, LD50/60 of 7.52 Gy, and an LD70/60 of 7.99 Gy with a relatively

2012 Health physics Controlled trial quality: uncertain PubMed abstract

171. A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications

A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01600521 Recruitment Status : Completed First Posted : May 17, 2012 Last Update Posted : April

2012 Clinical Trials

172. A Study in Healthy Volunteers to Evaluate Effects of Pre-Medication or Slow Dose Titration on Flushing and Gastrointestinal Events

, and flatulence) during the 24 hours prior to each AM dose. Participants were to answer the questions at the same time each day, before the morning drug administration. Secondary Outcome Measures : Number of Participants With Treatment-Emergent Adverse Events (AEs) or Serious AEs (SAEs) [ Time Frame: Day 1 up to end of Safety Follow-up (9 weeks) ] AE: any untoward medical occurrence that does not necessarily have a causal relationship with treatment. SAE: any untoward medical occurrence that at any dose (...) A Study in Healthy Volunteers to Evaluate Effects of Pre-Medication or Slow Dose Titration on Flushing and Gastrointestinal Events Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save

2012 Clinical Trials

173. A cross-sectional study of the association between overnight call and irritable bowel syndrome in medical students (Full text)

A cross-sectional study of the association between overnight call and irritable bowel syndrome in medical students Shift work has been associated with irritable bowel syndrome (IBS), which includes gastrointestinal symptoms such as abdominal pain, constipation and diarrhea. Overnight call shifts also lead to a disruption of the endogenous circadian rhythm.Medical students who perform intermittent overnight call shifts will demonstrate a higher prevalence of IBS symptoms when compared (...) measure (IBS-QOL). The prevalence of IBS symptoms and quality of life secondary to those symptoms were determined.Data were available for 247 medical students (110 preclinical students, 118 clerkship students and 19 excluded surveys). There was no significant difference in the presence of IBS between preclinical and clerkship students (21 of 110 [19.1%] versus 26 of 118 [22.0%]; P=0.58). The were no significant differences in mean (± SD) IBS-QOL score of those with IBS between preclinical (43.5±8.3

2012 Canadian Journal of Gastroenterology PubMed abstract

174. Secondary Adrenal Insufficiency

Secondary Adrenal Insufficiency Secondary Adrenal Insufficiency - Endocrine and Metabolic Disorders - MSD Manual Professional Edition Brought to you by The trusted provider of medical information since 1899 SEARCH SEARCH MEDICAL TOPICS Common Health Topics Resources QUIZZES & CASES Quizzes Cases The trusted provider of medical information since 1899 SEARCH SEARCH MEDICAL TOPICS Common Health Topics Resources QUIZZES & CASES Quizzes Cases / / / / IN THIS TOPIC OTHER TOPICS IN THIS CHAPTER Test (...) Endocrine System Video Overview of Buffering and the Henderson-Hasselbalch Equation SOCIAL MEDIA Add to Any Platform Loading , MD, University of Oxford; Fellow, Green-Templeton College Click here for Patient Education NOTE: This is the Professional Version. CONSUMERS: Topic Resources Secondary adrenal insufficiency is adrenal hypofunction due to a lack of adrenocorticotropic hormone (ACTH). Symptoms are the same as for and include fatigue, weakness, weight loss, nausea, vomiting, and diarrhea

2013 Merck Manual (19th Edition)

175. Secondary Iron Overload

Secondary Iron Overload Secondary Iron Overload - Hematology and Oncology - MSD Manual Professional Edition Brought to you by The trusted provider of medical information since 1899 SEARCH SEARCH MEDICAL TOPICS Common Health Topics Resources QUIZZES & CASES Quizzes Cases The trusted provider of medical information since 1899 SEARCH SEARCH MEDICAL TOPICS Common Health Topics Resources QUIZZES & CASES Quizzes Cases / / / / IN THIS TOPIC OTHER TOPICS IN THIS CHAPTER Test your knowledge Multiple (...) Biopsy SOCIAL MEDIA Add to Any Platform Loading , MD, Johns Hopkins University School of Medicine Click here for Patient Education NOTE: This is the Professional Version. CONSUMERS: Secondary iron overload results from excess absorption of iron, repeated blood transfusions, or excess oral intake, typically in patients with disorders of erythropoiesis. Consequences can include systemic symptoms, liver disorders, cardiomyopathy, diabetes, erectile dysfunction, and arthropathy. Diagnosis is by elevated

2013 Merck Manual (19th Edition)

176. Secondary Erythrocytosis

Secondary Erythrocytosis Secondary Erythrocytosis - Hematology and Oncology - MSD Manual Professional Edition Brought to you by The trusted provider of medical information since 1899 SEARCH SEARCH MEDICAL TOPICS Common Health Topics Resources QUIZZES & CASES Quizzes Cases The trusted provider of medical information since 1899 SEARCH SEARCH MEDICAL TOPICS Common Health Topics Resources QUIZZES & CASES Quizzes Cases / / / / IN THIS TOPIC OTHER TOPICS IN THIS CHAPTER Test your knowledge Multiple (...) of ADP Receptor ADP receptors are integral proteins embedded in a platelet membrane. When ADP binds, it causes a conformational change in the fibrinogen receptor, which allows fibrinogen to bind to the receptors... SOCIAL MEDIA Add to Any Platform Loading , MD, James P. Wilmot Cancer Institute, University of Rochester Medical Center; , MD, University of Rochester Medical Center Click here for Patient Education NOTE: This is the Professional Version. CONSUMERS: Secondary erythrocytosis

2013 Merck Manual (19th Edition)

177. Prevention of Irinotecan Induced Diarrhea by Probiotics

cycles the starting dose is 3x1 cps per day, or the dose according to dose adjustments from the previous treatment cycle. Outcome Measures Go to Primary Outcome Measures : Prevention of grade 3-4 diarrhea by probiotics in patients treated by irinotecan based chemotherapy [ Time Frame: 2 years ] Secondary Outcome Measures : Prevention of any grade of diarrhea [ Time Frame: 2 years ] Number of patients with any grade 3 or 4 toxicity or SAE related toxicity. [ Time Frame: 2 years ] Number of patients (...) Prevention of Irinotecan Induced Diarrhea by Probiotics Prevention of Irinotecan Induced Diarrhea by Probiotics - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Prevention of Irinotecan Induced Diarrhea

2011 Clinical Trials

178. Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea

to Prevent ETEC Diarrhea The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01382095 Recruitment Status : Completed First Posted : June 27, 2011 Last Update Posted : April 27, 2015 Sponsor: U.S. Army Medical Research and Materiel Command Information provided by (Responsible Party): U.S. Army Medical Research (...) Reed Army Institute of Research ) First Posted: June 27, 2011 Last Update Posted: April 27, 2015 Last Verified: April 2015 Keywords provided by U.S. Army Medical Research and Materiel Command: ETEC Diarrhea Vaccine Additional relevant MeSH terms: Layout table for MeSH terms Escherichia coli Infections Enterobacteriaceae Infections Gram-Negative Bacterial Infections Bacterial Infections

2011 Clinical Trials

179. Early Administration of Lactose-free Milk in Children Presenting With Acute Diarrhea

adding more. Early Administration of Lactose-free Milk in Children Presenting With Acute Diarrhea The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01269892 Recruitment Status : Completed First Posted : January 4, 2011 Last Update Posted : January 4, 2011 Sponsor: Isfahan University of Medical Sciences (...) Information provided by: Isfahan University of Medical Sciences Study Details Study Description Go to Brief Summary: The purpose of this study is to determine which nutritional regime is better for acute diarrhea in outcomes. Condition or disease Intervention/treatment Phase Acute Diarrhea Dietary Supplement: lactose-free milk Dietary Supplement: conventional milk Phase 2 Detailed Description: Diarrhea is still the most important cause of mortality and morbidity in children of the developing countries. We

2011 Clinical Trials

180. A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome

A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have (...) reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01494233

2011 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>